EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer’s Coordinating Center database

Davis C Woodworth, Katelynn M Nguyen, Lorena Sordo, Kiana A Scambray, Elizabeth Head, Claudia H Kawas, María M Corrada, Peter T Nelson, S Ahmad Sajjadi iD

Acta Neuropathologica · 2024

DOI: 10.1007/s00401-024-02728-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, 2024. Verfasst von Davis C Woodworth und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of California, Irvine, Office 364, Med Surge II Building, Irvine, CA, 92697, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, DNA-Binding Proteins, TDP-43 Proteinopathies. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TDP-43 proteinopathy is a salient neuropathologic feature in a subset of frontotemporal lobar degeneration (FTLD-TDP), in amyotrophic lateral sclerosis (ALS-TDP), and in limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC), and is associated with hippocampal sclerosis of aging (HS-A). We examined TDP-43-related pathology data in the National Alzheimer’s Coordinating Center (NACC) in two parts: (I) availability of assessments, and (II) associations with clinical diagnoses and other neuropathologies in those with all TDP-43 measures available. Part I: Of 4326 participants with neuropathology data collected using forms that included TDP-43 assessments, data availability was highest for HS-A (97%) and ALS (94%), followed by FTLD-TDP (83%). Regional TDP-43 pathologic assessment was available for 77% of participants, with hippocampus the most common region. Availability for the TDP-43-related measures increased over time, and was higher in centers with high proportions of participants with clinical FTLD. Part II: In 2142 participants with all TDP-43-related assessments available, 27% of participants had LATE-NC, whereas ALS-TDP or FTLD-TDP (ALS/FTLD-TDP) was present in 9% of participants, and 2% of participants had TDP-43 related to other pathologies (“Other TDP-43”). HS-A was present in 14% of participants, of whom 55% had LATE-NC, 20% ASL/FTLD-TDP, 3% Other TDP-43, and 23% no TDP-43. LATE-NC, ALS/FTLD-TDP, and Other TDP-43, were each associated with higher odds of dementia, HS-A, and hippocampal atrophy, compared to those without TDP-43 pathology. LATE-NC was associated with higher odds for Alzheimer’s disease (AD) clinical diagnosis, AD neuropathologic change (ADNC), Lewy bodies, arteriolosclerosis, and cortical atrophy. ALS/FTLD-TDP was associated with higher odds of clinical diagnoses of primary progressive aphasia and behavioral-variant frontotemporal dementia, and cortical/frontotemporal lobar atrophy. When using NACC data for TDP-43-related analyses, researchers should carefully consider the incomplete availability of the different regional TDP-43 assessments, the high frequency of participants with ALS/FTLD-TDP, and the presence of other forms of TDP-43 pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDNA-Binding ProteinsTDP-43 ProteinopathiesHumansFemaleAgedMaleAged, 80 and overDatabases, FactualFrontotemporal Lobar DegenerationBrainAmyotrophic Lateral SclerosisHippocampusMiddle Aged

Stichwörter der Autor:innen

Alzheimer’s diseaseAmyotrophic lateral sclerosisDementiaFrontotemporal lobar degenerationHippocampal sclerosis of agingLimbic predominant age-related TDP-43 encephalopathy neuropathologic changeNational Alzheimer’s coordinating centerTDP-43

Substanzen

DNA-Binding ProteinsTARDBP protein, human

Autor:innen und Institutionen

  • Department of Neurology, University of California, Irvine, Office 364, Med Surge II Building, Irvine, CA, 92697, USA.
  • Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, CA, USA.
  • Department of Pathology and Laboratory Medicine, University of California, Irvine, CA, USA.
  • Department of Neurobiology and Behavior, University of California, Irvine, CA, USA.
  • Department of Epidemiology and Biostatistics, University of California, Irvine, CA, USA.
  • Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, KY, USA.

ORCID-Profile: S Ahmad Sajjadi

Förderung

  • NIA NIH HHS
  • National Institute on Aging

Zitieren

APA

Woodworth, D. C., Nguyen, K. M., Sordo, L., Scambray, K. A., Head, E., Kawas, C. H., Corrada, M. M., Nelson, P. T., & Sajjadi, S. A. (2024). Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer’s Coordinating Center database. Acta Neuropathologica. https://doi.org/10.1007/s00401-024-02728-8

Vancouver

Woodworth DC, Nguyen KM, Sordo L, Scambray KA, Head E, Kawas CH, et al. Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer’s Coordinating Center database. Acta Neuropathologica. 2024. doi:10.1007/s00401-024-02728-8

BibTeX
@article{Woodworth2024,
  author = {Woodworth, Davis C and Nguyen, Katelynn M and Sordo, Lorena and Scambray, Kiana A and Head, Elizabeth and Kawas, Claudia H and Corrada, María M and Nelson, Peter T and Sajjadi, S Ahmad},
  title = {Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer’s Coordinating Center database},
  journal = {Acta Neuropathologica},
  year = {2024},
  doi = {10.1007/s00401-024-02728-8}
}
Kostenlos starten →